Oncostatin M and novel compositions having anti-neoplastic activity
US5120535A · kind A · utility
48Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 1987 |
| Grant date | Jun 9, 1992 |
| Priority date | — |
| Expiry date | May 4, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compositions are provided for modulating growth, particularly of tumor cells, which compositions are combinations of Oncostatin M, and one or both of transforming growth factors or .gamma.-interferons, or analogs thereof. In addition, a novel transforming growth factor is provided, designated TGF-.beta.2, as well as methods for its preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.